Search Results
LY341495 50mg 50mg | Purity Not Available
Adooq Bioscience
LY 341495 has been shown to be a highly potent and selective group II metabotropic glutamate receptor (mGluR-2) antagonist with Ki / IC50 values are 2.3, 1.3, 173, 990, 6800, 8200 and 22000 nM for human mGluR-2, mGluR-3, mGluR-8 , mGluR-7a, mGluR-1a, mGluR-5a and mGluR-4a.
More Information Supplier PageLY341495 25mg 25mg | Purity Not Available
Adooq Bioscience
LY 341495 has been shown to be a highly potent and selective group II metabotropic glutamate receptor (mGluR-2) antagonist with Ki / IC50 values are 2.3, 1.3, 173, 990, 6800, 8200 and 22000 nM for human mGluR-2, mGluR-3, mGluR-8 , mGluR-7a, mGluR-1a, mGluR-5a and mGluR-4a.
More Information Supplier PageLY341495 10mg 10mg | Purity Not Available
Adooq Bioscience
LY 341495 has been shown to be a highly potent and selective group II metabotropic glutamate receptor (mGluR-2) antagonist with Ki / IC50 values are 2.3, 1.3, 173, 990, 6800, 8200 and 22000 nM for human mGluR-2, mGluR-3, mGluR-8 , mGluR-7a, mGluR-1a, mGluR-5a and mGluR-4a.
More Information Supplier PageLaropiprant 50mg 50mg | Purity Not Available
Adooq Bioscience
Laropiprant is used in combination with niacin to reduce blood cholesterol. Laropiprant acts as a DP1 antagonist, reducing the vasodilation.
More Information Supplier PageLaropiprant 5mg 5mg | Purity Not Available
Adooq Bioscience
Laropiprant is used in combination with niacin to reduce blood cholesterol. Laropiprant acts as a DP1 antagonist, reducing the vasodilation.
More Information Supplier PageLaropiprant 25mg 25mg | Purity Not Available
Adooq Bioscience
Laropiprant is used in combination with niacin to reduce blood cholesterol. Laropiprant acts as a DP1 antagonist, reducing the vasodilation.
More Information Supplier PageKi 20227 10mg 10mg | Purity Not Available
Adooq Bioscience
KX2-391 dihydrochloride 5mg 5mg | Purity Not Available
Adooq Bioscience
KX2-391 2Hcl is the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.
More Information Supplier PageKX2-391 dihydrochloride 25mg 25mg | Purity Not Available
Adooq Bioscience
KX2-391 2Hcl is the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.
More Information Supplier Page